1000 related articles for article (PubMed ID: 19324127)
21. An evaluation of the number of lymph nodes examined and survival for node-negative esophageal carcinoma: data from China.
Yang HX; Xu Y; Fu JH; Wang JY; Lin P; Rong TH
Ann Surg Oncol; 2010 Jul; 17(7):1901-11. PubMed ID: 20146101
[TBL] [Abstract][Full Text] [Related]
22. [Clinical implications of the new TNM staging system for thoracic esophageal squamous cell carcinoma].
Fang WT; Feng J; Mao T; Fu SJ; Chen WH
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):687-91. PubMed ID: 22340051
[TBL] [Abstract][Full Text] [Related]
23. [Clinical study of lymph node metastatic pattern of thoracic esophageal squamous carcinoma].
Xie YT; Wang SQ; Zuo Q; Huang JQ; An FS; Chen SH; Luo RC
Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):573-4. PubMed ID: 15897141
[TBL] [Abstract][Full Text] [Related]
24. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors?
Bollschweiler E; Baldus SE; Schröder W; Schneider PM; Hölscher AH
J Surg Oncol; 2006 Oct; 94(5):355-63. PubMed ID: 16967455
[TBL] [Abstract][Full Text] [Related]
25. Lymph node dissection for thoracic esophageal carcinoma. Two- and 3-field lymph node dissection.
Kato H
Ann Chir Gynaecol; 1995; 84(2):193-9. PubMed ID: 7574380
[TBL] [Abstract][Full Text] [Related]
26. [Characteristics of lymph node metastasis in thoracic esophageal carcinoma].
Li JD; Wang WG; Xu JL; Gao ZR; Shao LF
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(45):3197-200. PubMed ID: 17313786
[TBL] [Abstract][Full Text] [Related]
27. Developing an appropriate staging system for esophageal carcinoma.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
J Am Coll Surg; 2005 Dec; 201(6):884-90. PubMed ID: 16310691
[TBL] [Abstract][Full Text] [Related]
28. The pattern of lymphatic metastases in superficial squamous cell carcinoma of the esophagus.
Gotohda N; Nishimura M; Yoshida J; Nagai K; Tanaka N
Hepatogastroenterology; 2005; 52(61):105-7. PubMed ID: 15783006
[TBL] [Abstract][Full Text] [Related]
29. Surgical outcome of patients with thoracic esophageal cancer positive for cervical lymph nodes.
Shimada H; Shiratori T; Okazumi S; Matsubara H; Nabeya Y; Shuto K; Shimizu T; Hayashi H; Ochiai T
Hepatogastroenterology; 2007; 54(73):100-3. PubMed ID: 17419240
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of lymph node metastases of 217 cases of thoracic esophageal carcinoma and its impact on prognosis].
An FS; Huang JQ; Chen SH
Ai Zheng; 2003 Sep; 22(9):974-7. PubMed ID: 12969532
[TBL] [Abstract][Full Text] [Related]
31. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
[TBL] [Abstract][Full Text] [Related]
32. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection.
Peyre CG; Hagen JA; DeMeester SR; Altorki NK; Ancona E; Griffin SM; Hölscher A; Lerut T; Law S; Rice TW; Ruol A; van Lanschot JJ; Wong J; DeMeester TR
Ann Surg; 2008 Oct; 248(4):549-56. PubMed ID: 18936567
[TBL] [Abstract][Full Text] [Related]
33. [Impact of number and extent of lymph node metastasis on prognosis of thoracic esophageal cancer].
FENG J; MAO T; CHEN WH; FANG WT
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Sep; 14(9):715-8. PubMed ID: 21948541
[TBL] [Abstract][Full Text] [Related]
34. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.
Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
Ann Surg Oncol; 2007 Feb; 14(2):306-16. PubMed ID: 17091329
[TBL] [Abstract][Full Text] [Related]
35. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
[TBL] [Abstract][Full Text] [Related]
36. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined.
Cianchi F; Palomba A; Boddi V; Messerini L; Pucciani F; Perigli G; Bechi P; Cortesini C
World J Surg; 2002 Mar; 26(3):384-9. PubMed ID: 11865379
[TBL] [Abstract][Full Text] [Related]
37. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors.
Tajima Y; Nakanishi Y; Ochiai A; Tachimori Y; Kato H; Watanabe H; Yamaguchi H; Yoshimura K; Kusano M; Shimoda T
Cancer; 2000 Mar; 88(6):1285-93. PubMed ID: 10717608
[TBL] [Abstract][Full Text] [Related]
38. Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma.
Sato F; Shimada Y; Li Z; Watanabe G; Maeda M; Imamura M
Br J Surg; 2001 Mar; 88(3):426-32. PubMed ID: 11260111
[TBL] [Abstract][Full Text] [Related]
39. Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma.
Nakamori M; Iwahashi M; Nakamura M; Yamaue H
J Surg Oncol; 2003 Sep; 84(1):10-6. PubMed ID: 12949985
[TBL] [Abstract][Full Text] [Related]
40. [Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus].
Wu J; Chai Y; Zhou XM; Chen QX; Yan FL
Ai Zheng; 2007 Mar; 26(3):307-11. PubMed ID: 17355797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]